Teva Continues Restructuring With 46 Cuts in Pennsylvania Post author:Sam Post published:February 7, 2018 Post category:BioPharma The cuts were apparently announced in late January with a WARN notice filed with the state. Source: BioSpace You Might Also Like Bay Area's Coherus Craters After the FDA Spurns Its Biosimilar for Amgen's Neulasta June 11, 2017 3 Biotechs Under $5 With Jaw-Dropping Growth Potential March 8, 2017 Little reMYND Forges 350M+ Euros Tie-Up With Drug Giant Novo Nordisk December 13, 2017